InvestorsHub Logo
icon url

dewophile

10/28/20 2:20 PM

#235317 RE: biocqr #235316

Thanks for the reply and info
I assume that the KALA drug will be priced at a premium to Lotemax. Has their proprietary formulation shown better efficacy and/or safety to Lotemax to justify its use over a cheaper alternative? Is the dose much lower given the improved penetration?